DE69901934D1 - 4-(2-keto-1-benzimidazolinyl)piperidin derivate als orl1-rezeptor agoniste - Google Patents

4-(2-keto-1-benzimidazolinyl)piperidin derivate als orl1-rezeptor agoniste

Info

Publication number
DE69901934D1
DE69901934D1 DE69901934T DE69901934T DE69901934D1 DE 69901934 D1 DE69901934 D1 DE 69901934D1 DE 69901934 T DE69901934 T DE 69901934T DE 69901934 T DE69901934 T DE 69901934T DE 69901934 D1 DE69901934 D1 DE 69901934D1
Authority
DE
Germany
Prior art keywords
agoniste
benzimidazolinyl
keto
piperidine derivatives
orl1 receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69901934T
Other languages
English (en)
Other versions
DE69901934T2 (de
Inventor
Fumitaka Ito
Hiroshi Kondo
Hirohide Noguchi
Yoriko Ohashi
Tatsuya Yamagishi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of DE69901934D1 publication Critical patent/DE69901934D1/de
Publication of DE69901934T2 publication Critical patent/DE69901934T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DE69901934T 1998-01-19 1999-01-08 4-(2-keto-1-benzimidazolinyl)piperidin derivate als orl1-rezeptor agoniste Expired - Fee Related DE69901934T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IB9800069 1998-01-19
PCT/IB1999/000012 WO1999036421A1 (en) 1998-01-19 1999-01-08 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists

Publications (2)

Publication Number Publication Date
DE69901934D1 true DE69901934D1 (de) 2002-08-01
DE69901934T2 DE69901934T2 (de) 2002-11-07

Family

ID=11004651

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69901934T Expired - Fee Related DE69901934T2 (de) 1998-01-19 1999-01-08 4-(2-keto-1-benzimidazolinyl)piperidin derivate als orl1-rezeptor agoniste

Country Status (30)

Country Link
US (1) US6423725B1 (de)
EP (1) EP1049689B1 (de)
JP (1) JP3342478B2 (de)
CN (1) CN1288464A (de)
AP (1) AP9901442A0 (de)
AR (1) AR014421A1 (de)
AT (1) ATE219772T1 (de)
AU (1) AU1679099A (de)
BG (1) BG104670A (de)
BR (1) BR9907104A (de)
CA (1) CA2317462C (de)
CO (1) CO4990962A1 (de)
DE (1) DE69901934T2 (de)
DK (1) DK1049689T3 (de)
EA (1) EA200000683A1 (de)
ES (1) ES2175925T3 (de)
GT (1) GT199900008A (de)
IL (1) IL137149A0 (de)
IS (1) IS5539A (de)
MA (1) MA26598A1 (de)
NO (1) NO20003671L (de)
OA (1) OA11445A (de)
PA (1) PA8467101A1 (de)
PE (1) PE20000166A1 (de)
PL (1) PL342046A1 (de)
PT (1) PT1049689E (de)
TN (1) TNSN99006A1 (de)
TR (1) TR200002090T2 (de)
WO (1) WO1999036421A1 (de)
ZA (1) ZA99314B (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6262066B1 (en) 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
DE69923744T2 (de) * 1998-10-23 2006-02-23 Pfizer Inc. 1,3,8-Triazaspiro[4,5] decanon Verbindungen als orl1-receptor Agonisten
AU1185300A (en) * 1998-11-20 2000-06-13 Banyu Pharmaceutical Co., Ltd. 2-oxoimidazole derivatives
SE9903544D0 (sv) 1999-10-01 1999-10-01 Astra Pharma Prod Novel compounds
EP1221443B1 (de) 1999-10-13 2004-09-01 Banyu Pharmaceutical Co., Ltd. Substituierte imidazolin-derivate
DE60033071T2 (de) 1999-12-06 2007-08-23 Euro-Celtique S.A. Triazospiroverbindungen mit nociceptin-rezeptoraffinität
AU2063201A (en) 1999-12-06 2001-06-12 Euro-Celtique S.A. Tertiary amino compounds having opioid receptor affinity
JP2003524634A (ja) * 1999-12-06 2003-08-19 ユーロ−セルティーク，エス．エイ． ノシセプチン受容体親和性を有するベンズイミダゾール化合物
GB2359078A (en) 2000-02-11 2001-08-15 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
GB2359081A (en) 2000-02-11 2001-08-15 Astrazeneca Uk Ltd Pharmaceutically active thiazolopyrimidines
GB2359551A (en) 2000-02-23 2001-08-29 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
GB0005642D0 (en) 2000-03-10 2000-05-03 Astrazeneca Uk Ltd Chemical compounds
SE0003828D0 (sv) 2000-10-20 2000-10-20 Astrazeneca Ab Novel compounds
US6969712B2 (en) 2000-11-15 2005-11-29 Banyu Pharmaceutical Co., Ltd. Benzimidazole derivatives
SE0101322D0 (sv) 2001-04-12 2001-04-12 Astrazeneca Ab Novel compounds
MXPA03009602A (es) 2001-04-18 2004-04-02 Euro Celtique Sa Analogos de nociceptina.
PT1379246E (pt) * 2001-04-18 2009-01-14 Euro Celtique Sa Análogos de nociceptina
DK1975164T3 (da) 2001-04-18 2010-05-25 Euro Celtique Sa Octahydrobenzimidazolon-forbindelser som analgetika
DE60229736D1 (de) 2001-04-18 2008-12-18 Euro Celtique Sa Spiroinden- und spiroindan-verbindungen
AU2002311833B2 (en) 2001-04-18 2005-04-28 Euro-Celtique S.A. Spiropyrazole compounds
DE10123163A1 (de) 2001-05-09 2003-01-16 Gruenenthal Gmbh Substituierte Cyclohexan-1,4-diaminderivate
JP3896309B2 (ja) 2001-07-09 2007-03-22 ファイザー株式会社 プロテインキナーゼｃ阻害物質としてのピラゾロキノリノン誘導体
EP1491212B1 (de) * 2002-03-29 2012-08-08 Mitsubishi Tanabe Pharma Corporation Mittel zur behandlung von schlafstörungen
JP2005289816A (ja) * 2002-05-14 2005-10-20 Banyu Pharmaceut Co Ltd ベンズイミダゾール誘導体
GB0221828D0 (en) 2002-09-20 2002-10-30 Astrazeneca Ab Novel compound
DE50312412D1 (en) 2002-11-12 2010-03-25 Gruenenthal Gmbh 4-hydroxymethyl-1-aryl-cyclohexylamin-derivative
US8067603B2 (en) 2003-09-25 2011-11-29 Solvay Pharmaceuticals B.V. Benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors
AR045843A1 (es) 2003-10-03 2005-11-16 Solvay Pharm Bv Derivados de bencimidazolonas y quinazolinonas sustituidas con hidronopol como agonistas en receptores orl 1 humanos
GB0328243D0 (en) 2003-12-05 2004-01-07 Astrazeneca Ab Methods
US7300947B2 (en) * 2005-07-13 2007-11-27 Banyu Pharmaceutical Co., Ltd. N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives
AR054816A1 (es) * 2005-07-13 2007-07-18 Banyu Pharma Co Ltd Derivados de n-dihidroxialquil 2-oxo- imidazol sustituidos
US20090111778A1 (en) * 2005-11-18 2009-04-30 Richard Apodaca 2-Keto-Oxazoles as Modulators of Fatty Acid Amide Hydrolase
US8354434B2 (en) 2006-01-30 2013-01-15 Purdue Pharma L.P. Cyclourea compounds as calcium channel blockers
GB0605784D0 (en) * 2006-03-22 2006-05-03 Glaxo Group Ltd Compounds
GB0605786D0 (en) * 2006-03-22 2006-05-03 Glaxo Group Ltd Compounds
BRPI0717161A2 (pt) * 2006-10-16 2013-10-15 Mitsubishi Tanabe Pharma Corp Agente para profilaxia ou tratamento de abuso e dependência de substância.
SI2076506T1 (sl) * 2007-01-16 2011-01-31 Purdue Pharma Lp Heterociklično substituirani piperidini kot ORL-1 ligandi
JP5313865B2 (ja) * 2007-03-01 2013-10-09 田辺三菱製薬株式会社 ベンゾイミダゾール化合物およびその医薬用途
EP2433936A1 (de) 2007-08-31 2012-03-28 Purdue Pharma LP Piperidinverbindungen vom substituierten Chinoxalintyp und Anwendungen davon
US8119661B2 (en) 2007-09-11 2012-02-21 Astrazeneca Ab Piperidine derivatives and their use as muscarinic receptor modulators
TW201016675A (en) 2008-09-16 2010-05-01 Mitsubishi Tanabe Pharma Corp Crystalline benzoimidazole compound and salt thereof
EP2582681A1 (de) * 2010-06-17 2013-04-24 Novartis AG Piperidinylsubstituierte 1,3-dihydro-benzoimidazol-2-ylidenaminderivate
WO2014153529A1 (en) 2013-03-22 2014-09-25 The Scripps Research Institute Substituted benzimidazoles as nociceptin receptor modulators
CA3044950A1 (en) * 2016-11-28 2018-05-31 Mitsubishi Tanabe Pharma Corporation Drug for treating cocaine addiction or preventing recurrence of same
US11739070B2 (en) 2018-01-19 2023-08-29 Idorsia Pharmaceuticals Ltd. C5A receptor modulators

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3161645A (en) * 1962-12-18 1964-12-15 Res Lab Dr C Janssen N V 1-(1-aroylpropyl-4-piperidyl)-2-benzimidazolinones and related compounds
US3318900A (en) * 1964-05-06 1967-05-09 Janssen Pharmaceutica Nv Derivatives of benzimidazolinyl piperidine
JPS58180481A (ja) * 1982-04-15 1983-10-21 Kyowa Hakko Kogyo Co Ltd 新規なピペリジン誘導体
AT388731B (de) 1987-12-15 1989-08-25 Gerot Pharmazeutika Neue derivate von benzimidazol, ihre herstellung und verwendung
WO1997016186A1 (en) 1995-10-31 1997-05-09 Merck & Co., Inc. Muscarine agonists
ZA9610745B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
EP0898568B1 (de) * 1996-04-19 2006-10-04 Neurosearch A/S 1-(4-piperidyl)-benzimidazole mit neurotropher aktivität
ATE276242T1 (de) 1997-05-30 2004-10-15 Banyu Pharma Co Ltd 2-oxoimidazol-derivate

Also Published As

Publication number Publication date
CN1288464A (zh) 2001-03-21
DE69901934T2 (de) 2002-11-07
AP9901442A0 (en) 1999-03-31
US6423725B1 (en) 2002-07-23
AR014421A1 (es) 2001-02-28
CA2317462C (en) 2005-09-13
EA200000683A1 (ru) 2000-12-25
TNSN99006A1 (fr) 2005-11-10
CO4990962A1 (es) 2000-12-26
PT1049689E (pt) 2002-09-30
ATE219772T1 (de) 2002-07-15
IS5539A (is) 2000-06-16
EP1049689A1 (de) 2000-11-08
CA2317462A1 (en) 1999-07-22
DK1049689T3 (da) 2002-07-22
IL137149A0 (en) 2001-07-24
NO20003671L (no) 2000-09-18
ZA99314B (en) 2000-07-18
OA11445A (en) 2004-04-30
AU1679099A (en) 1999-08-02
MA26598A1 (fr) 2004-12-20
JP2002509148A (ja) 2002-03-26
PA8467101A1 (es) 2000-09-29
PL342046A1 (en) 2001-05-21
PE20000166A1 (es) 2000-03-07
JP3342478B2 (ja) 2002-11-11
BR9907104A (pt) 2000-10-24
EP1049689B1 (de) 2002-06-26
BG104670A (en) 2001-05-31
GT199900008A (es) 2000-07-12
TR200002090T2 (tr) 2000-11-21
WO1999036421A1 (en) 1999-07-22
ES2175925T3 (es) 2002-11-16
NO20003671D0 (no) 2000-07-18

Similar Documents

Publication Publication Date Title
DE69901934D1 (de) 4-(2-keto-1-benzimidazolinyl)piperidin derivate als orl1-rezeptor agoniste
DE60021371D1 (de) Piperidinderivate verwendbar als ccr5 antagonisten
ATE288898T1 (de) Phenylethenyl- oder phenylethinylderivate als glutamatrezeptorantagonisten
ATE420863T1 (de) Substituierte piperidinverbindungen zur verwendung als h3 histaminerezeptorantagonisten
CH1175401H1 (de) Piperazin Derivate verwendbar als CCR5 Antagonisten
ATE328871T1 (de) 4-phenyl-pyridin-derivate verwendbar als neurokinin-1 rezeptor antagonisten
DE60032601D1 (de) Als antikrebsmittel verwendbare heterocyklische derivate
ATE259363T1 (de) Piperazinderivate als 5-ht1b antagonisten
DE60318697D1 (de) Triazolderivate als tachykininrezeptor-antagonisten
NO20026125D0 (no) Tetrahydropyridin- eller piperidin-heterocykliske derivater
ATE386720T1 (de) Piperidin ccr-3 rezeptor-hemmer
ATE400554T1 (de) 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives als muskarin-rezeptor antagonisten
DE60203481D1 (de) Piperidinderivate als neurokinin 1 antagonisten
DE60314170D1 (de) Substituierte 4-amino-1-(pyridylmethyl)piperidine zur verwendung als muscarinrezeptor-antagonisten
ATE286022T1 (de) Naphthalin-carboxamide als tachykinin rezeptorantagonisten
ATE247105T1 (de) Antipsychotische 4-(1h-indolyl-1-yl)-1- substituierte piperidine derivate
DE50100358D1 (de) Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten
ATE338043T1 (de) 5-methoxy-8-aryl- 1,2,4ötriazolo 1,5-aöpyridine derivative als adenosin-rezeptor antagonisten
ATE315025T1 (de) Ethansulfonyl-piperidin-derivate
ATE236150T1 (de) (4-piperidinyl)-1h-2-benzopyran derivate verwendbar als antipsychotische mittel
ATE361911T1 (de) Piperidinderivate als ccr5-rezeptormodulatoren
NO20002430D0 (no) Anordning for gulvsluk
DE60139781D1 (de) 4-substituierte piperidinverbindung
TR199800596A3 (tr) Fenoksimetil piperidin türevleri

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee